clorgyline has been researched along with Androgen-Independent Prostatic Cancer in 2 studies
Clorgyline: An antidepressive agent and monoamine oxidase inhibitor related to PARGYLINE.
clorgyline : An aromatic ether that is the 2,4-dichlorophenyl ether of 3-aminopropan-1-ol in which the nitrogen is substituted by a methyl group and a prop-1-yn-3-yl group. A monoamine oxidase inhibitor, it was formerly used as an antidepressant.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Wang, K | 1 |
Luo, J | 2 |
Yeh, S | 1 |
You, B | 1 |
Meng, J | 1 |
Chang, P | 1 |
Niu, Y | 1 |
Li, G | 1 |
Lu, C | 1 |
Zhu, Y | 1 |
Antonarakis, ES | 1 |
Huang, CP | 1 |
Xu, W | 1 |
Chang, C | 1 |
Gaur, S | 1 |
Gross, ME | 1 |
Liao, CP | 1 |
Qian, B | 1 |
Shih, JC | 1 |
2 other studies available for clorgyline and Androgen-Independent Prostatic Cancer
Article | Year |
---|---|
The MAO inhibitors phenelzine and clorgyline revert enzalutamide resistance in castration resistant prostate cancer.
Topics: Alternative Splicing; Animals; Benzamides; Cell Line, Tumor; Cell Proliferation; Clorgyline; Drug Re | 2020 |
Effect of Monoamine oxidase A (MAOA) inhibitors on androgen-sensitive and castration-resistant prostate cancer cells.
Topics: Androgen Antagonists; Benzamides; Carcinogenesis; Cell Line, Tumor; Cell Proliferation; Clorgyline; | 2019 |